Whilst oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (Her2) exhibit high concordance between sample pairs in these studies, the growing understanding of breast cancer as an increasingly heterogeneous and polygenic disease necessitates a high-throughput approach. This evidence concerns the gene PGR and breast cancer.